Symbols / NUWE Stock $1.14 -1.72% Nuwellis, Inc.
NUWE (Stock) Chart
Stock Fundamentals
|
|
|
|
|
|
About
Nuwellis, Inc., a medical device company, develops, manufactures, and commercializes medical devices used in ultrafiltration therapy. The company provides Aquadex FlexFlow and Aquadex SmartFlow systems, which are used to treat patients suffering from fluid overload due to heart failure. Its Aquadex FlexFlow system includes a console, disposable blood circuit set, and disposable catheter. The company sells its products to hospitals and clinics through its direct salesforce in the United States; and through specialty healthcare distributors in Austria, Belarus, Brazil, Colombia, the Czech Republic, Germany, Greece, Hong Kong, India, Indonesia, Israel, Italy, Panama, Romania, Singapore, Slovakia, Spain, Switzerland, Thailand, the United Arab Emirates, and the United Kingdom. The company was formerly known as CHF Solutions, Inc. and changed its name to Nuwellis, Inc. in April 2021. Nuwellis, Inc. was founded in 1999 and is headquartered in Eden Prairie, Minnesota.
Ratings
Latest analyst rating changes
| Date | Action | Analyst | Rating Change | Price Target |
|---|---|---|---|---|
| 2024-08-13 | reit | Roth MKM | Buy → Buy | $17 |
| 2024-07-29 | init | Roth MKM | — → Buy | $17 |
| 2023-11-08 | down | Ladenburg Thalmann | Buy → Neutral | — |
- Catheter cut to fit at bedside gets USPTO allowance for Nuwellis - Stock Titan ue, 28 Apr 2026 12
- Nuwellis (NUWE) Secures Patent Approval for Innovative Catheter Technology - GuruFocus ue, 28 Apr 2026 14
- NUWE Stock Price, Quote & Chart | NUWELLIS INC (NASDAQ:NUWE) - ChartMill Mon, 20 Apr 2026 07
- NUWE Price Today: Nuwellis, Inc. Stock Price, Quote & Chart | MEXC - MEXC Exchange Sun, 26 Apr 2026 14
- Nuwellis brings in CORE IR to sharpen investor outreach and social media - Stock Titan hu, 09 Apr 2026 07
- Here’s Why Nuwellis Stock (NUWE) Rocketed Today - TipRanks ue, 27 Jan 2026 08
- $NUWE ($NUWE) Releases Q4 2025 Earnings - Quiver Quantitative ue, 10 Mar 2026 07
- Nuwellis stock falls after CFO appointment announcement - Investing.com Fri, 30 Jan 2026 08
- Is Nuwellis Stock Built to Withstand More Downside? - Trefis Wed, 24 Dec 2025 08
- Nuwellis (NUWE) Stock: Trending Down? (Volatility Increases) 2026-04-18 - Professional Trade Ideas - UBND thành phố Hải Phòng Sat, 18 Apr 2026 11
- Chicago heart-surgery meeting puts Nuwellis' fluid-removal system on display - Stock Titan hu, 23 Apr 2026 12
- Nuwellis Settles Lawsuit With E.F. Hutton, Resolving Dispute - TipRanks Fri, 24 Apr 2026 22
- Nuwellis (NUWE) to pay $204,000 to settle E.F. Hutton lawsuit - Stock Titan Fri, 24 Apr 2026 21
- Nuwellis buys new kidney monitors to guide earlier care for sickest patients - Stock Titan ue, 17 Mar 2026 07
- Three former Nuwellis employees return as Aquadex expansion pushes on - Stock Titan hu, 16 Apr 2026 07
Financials
| Line Item | Trend | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|---|
| Total Revenue |
|
8.27
-5.38%
|
8.74
-1.40%
|
8.86
+3.76%
|
8.54
|
| Operating Revenue |
|
8.27
-5.38%
|
8.74
-1.40%
|
8.86
+3.76%
|
8.54
|
| Cost Of Revenue |
|
3.15
+2.68%
|
3.06
-21.05%
|
3.88
+2.46%
|
3.79
|
| Reconciled Cost Of Revenue |
|
3.15
+2.68%
|
3.06
-21.05%
|
3.88
+2.46%
|
3.79
|
| Gross Profit |
|
5.12
-9.73%
|
5.68
+13.91%
|
4.98
+4.79%
|
4.75
|
| Operating Expense |
|
16.23
-2.60%
|
16.66
-26.31%
|
22.61
+3.13%
|
21.93
|
| Research And Development |
|
2.71
-15.49%
|
3.21
-40.82%
|
5.42
+24.87%
|
4.34
|
| Selling General And Administration |
|
13.52
+0.47%
|
13.46
-21.73%
|
17.19
-2.23%
|
17.58
|
| Total Expenses |
|
19.38
-1.78%
|
19.73
-25.54%
|
26.49
+3.03%
|
25.71
|
| Operating Income |
|
-11.11
-1.07%
|
-10.99
+37.67%
|
-17.63
-2.67%
|
-17.17
|
| Total Operating Income As Reported |
|
-11.11
-1.07%
|
-10.99
+37.67%
|
-17.63
-2.67%
|
-17.17
|
| EBITDA |
|
-6.55
-24.85%
|
-5.24
+67.94%
|
-16.36
-234.00%
|
-4.90
|
| Normalized EBITDA |
|
-10.68
+0.73%
|
-10.76
+37.14%
|
-17.11
-2.33%
|
-16.72
|
| Reconciled Depreciation |
|
0.42
+34.52%
|
0.31
-14.36%
|
0.36
-2.69%
|
0.37
|
| EBIT |
|
-6.96
-25.39%
|
-5.55
+66.78%
|
-16.72
-217.29%
|
-5.27
|
| Total Unusual Items |
|
4.13
-25.06%
|
5.51
+627.57%
|
0.76
-93.59%
|
11.83
|
| Total Unusual Items Excluding Goodwill |
|
4.13
-25.06%
|
5.51
+627.57%
|
0.76
-93.59%
|
11.83
|
| Special Income Charges |
|
0.00
-100.00%
|
0.90
|
0.00
|
—
|
| Other Special Charges |
|
—
|
-0.90
|
—
|
—
|
| Net Income |
|
-17.52
-56.93%
|
-11.16
+44.75%
|
-20.21
-39.13%
|
-14.53
|
| Pretax Income |
|
-17.52
-56.95%
|
-11.16
+44.76%
|
-20.20
-39.16%
|
-14.52
|
| Net Non Operating Interest Income Expense |
|
-10.55
-88.21%
|
-5.61
-60.98%
|
-3.48
+62.33%
|
-9.25
|
| Interest Expense Non Operating |
|
10.55
+88.21%
|
5.61
+60.98%
|
3.48
-62.33%
|
9.25
|
| Net Interest Income |
|
-10.55
-88.21%
|
-5.61
-60.98%
|
-3.48
+62.33%
|
-9.25
|
| Interest Expense |
|
10.55
+88.21%
|
5.61
+60.98%
|
3.48
-62.33%
|
9.25
|
| Other Income Expense |
|
4.14
-23.77%
|
5.43
+495.94%
|
0.91
-92.34%
|
11.90
|
| Other Non Operating Income Expenses |
|
0.01
+112.50%
|
-0.08
-151.95%
|
0.15
+105.33%
|
0.07
|
| Gain On Sale Of Security |
|
4.13
-10.44%
|
4.62
+508.84%
|
0.76
-93.59%
|
11.83
|
| Tax Provision |
|
0.01
+0.00%
|
0.01
-37.50%
|
0.01
-11.11%
|
0.01
|
| Tax Rate For Calcs |
|
0.00
+0.00%
|
0.00
+0.00%
|
0.00
+0.00%
|
0.00
|
| Tax Effect Of Unusual Items |
|
0.87
-25.06%
|
1.16
+627.57%
|
0.16
-93.59%
|
2.48
|
| Net Income Including Noncontrolling Interests |
|
-17.52
-56.93%
|
-11.16
+44.75%
|
-20.21
-39.13%
|
-14.53
|
| Net Income From Continuing Operation Net Minority Interest |
|
-17.52
-56.93%
|
-11.16
+44.75%
|
-20.21
-39.13%
|
-14.53
|
| Net Income From Continuing And Discontinued Operation |
|
-17.52
-56.93%
|
-11.16
+44.75%
|
-20.21
-39.13%
|
-14.53
|
| Net Income Continuous Operations |
|
-17.52
-56.93%
|
-11.16
+44.75%
|
-20.21
-39.13%
|
-14.53
|
| Normalized Income |
|
-20.79
-33.91%
|
-15.52
+25.40%
|
-20.81
+12.82%
|
-23.87
|
| Net Income Common Stockholders |
|
-17.52
-64.88%
|
-10.62
+53.05%
|
-22.63
-55.78%
|
-14.53
|
| Diluted EPS |
|
-25.39
+92.81%
|
-353.22
+97.91%
|
-16,934.40
-1686.71%
|
-947.80
|
| Basic EPS |
|
-25.39
+92.81%
|
-353.22
+97.91%
|
-16,934.40
-1686.71%
|
-947.80
|
| Basic Average Shares |
|
0.69
+2083.93%
|
0.03
+2265.34%
|
0.00
+267.03%
|
0.00
|
| Diluted Average Shares |
|
0.69
+2083.93%
|
0.03
+2265.34%
|
0.00
+267.03%
|
0.00
|
| Diluted NI Availto Com Stockholders |
|
-17.52
-64.88%
|
-10.62
+53.05%
|
-22.63
-55.78%
|
-14.53
|
| Preferred Stock Dividends |
|
-0.00
+99.26%
|
-0.54
-122.37%
|
2.42
|
—
|
| Line Item | Trend | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|---|
| Total Assets |
|
6.12
-37.98%
|
9.86
+0.96%
|
9.77
-60.40%
|
24.67
|
| Current Assets |
|
5.19
-41.43%
|
8.86
+7.87%
|
8.21
-63.95%
|
22.77
|
| Cash Cash Equivalents And Short Term Investments |
|
1.08
-78.70%
|
5.09
+34.08%
|
3.80
-79.24%
|
18.31
|
| Cash And Cash Equivalents |
|
1.08
-78.70%
|
5.09
+34.08%
|
3.80
-78.58%
|
17.74
|
| Other Short Term Investments |
|
—
|
—
|
0.00
-100.00%
|
0.57
|
| Receivables |
|
1.49
-13.55%
|
1.73
-11.48%
|
1.95
+38.76%
|
1.41
|
| Accounts Receivable |
|
1.49
-13.55%
|
1.73
-11.48%
|
1.95
+38.76%
|
1.41
|
| Inventory |
|
1.91
+11.18%
|
1.72
-13.97%
|
2.00
-24.95%
|
2.66
|
| Raw Materials |
|
1.46
+11.22%
|
1.31
-11.01%
|
1.47
-8.51%
|
1.61
|
| Work In Process |
|
0.09
-32.82%
|
0.13
-36.71%
|
0.21
+1.47%
|
0.20
|
| Finished Goods |
|
0.45
-13.09%
|
0.51
+30.28%
|
0.39
-60.42%
|
0.99
|
| Other Current Assets |
|
0.70
+121.59%
|
0.32
-31.67%
|
0.46
+16.41%
|
0.40
|
| Total Non Current Assets |
|
0.93
-7.63%
|
1.01
-35.36%
|
1.56
-18.01%
|
1.90
|
| Net PPE |
|
0.66
-33.10%
|
0.99
-31.44%
|
1.44
-23.47%
|
1.88
|
| Gross PPE |
|
4.64
-2.66%
|
4.77
-3.19%
|
4.92
-2.59%
|
5.05
|
| Accumulated Depreciation |
|
-3.98
-5.29%
|
-3.78
-8.50%
|
-3.48
-9.81%
|
-3.17
|
| Properties |
|
0.00
|
0.00
|
0.00
|
0.00
|
| Machinery Furniture Equipment |
|
1.07
+0.47%
|
1.07
+0.38%
|
1.06
-2.83%
|
1.09
|
| Other Properties |
|
3.31
-3.83%
|
3.45
-4.46%
|
3.61
-2.70%
|
3.71
|
| Leases |
|
0.25
+0.00%
|
0.25
+0.00%
|
0.25
+0.00%
|
0.25
|
| Other Non Current Assets |
|
0.27
+1190.48%
|
0.02
-82.50%
|
0.12
+471.43%
|
0.02
|
| Total Liabilities Net Minority Interest |
|
3.49
+4.62%
|
3.33
-49.17%
|
6.56
-46.74%
|
12.32
|
| Current Liabilities |
|
3.03
+18.48%
|
2.56
-19.33%
|
3.17
-32.34%
|
4.69
|
| Payables And Accrued Expenses |
|
2.23
+35.73%
|
1.64
-31.09%
|
2.38
+6.01%
|
2.25
|
| Payables |
|
2.23
+35.73%
|
1.64
-31.09%
|
2.38
+6.01%
|
2.25
|
| Accounts Payable |
|
2.23
+35.73%
|
1.64
-31.09%
|
2.38
+6.01%
|
2.25
|
| Pensionand Other Post Retirement Benefit Plans Current |
|
0.46
-28.13%
|
0.64
+21.90%
|
0.53
-75.71%
|
2.16
|
| Current Debt And Capital Lease Obligation |
|
0.26
+9.66%
|
0.24
+10.19%
|
0.22
-3.57%
|
0.22
|
| Current Capital Lease Obligation |
|
0.26
+9.66%
|
0.24
+10.19%
|
0.22
-3.57%
|
0.22
|
| Other Current Liabilities |
|
0.09
+107.32%
|
0.04
-19.61%
|
0.05
-12.07%
|
0.06
|
| Total Non Current Liabilities Net Minority Interest |
|
0.46
-41.16%
|
0.78
-77.12%
|
3.39
-55.60%
|
7.63
|
| Long Term Debt And Capital Lease Obligation |
|
0.07
-78.18%
|
0.31
-43.57%
|
0.54
-28.42%
|
0.76
|
| Long Term Capital Lease Obligation |
|
0.07
-78.18%
|
0.31
-43.57%
|
0.54
-28.42%
|
0.76
|
| Other Non Current Liabilities |
|
—
|
—
|
—
|
—
|
| Stockholders Equity |
|
2.63
-59.72%
|
6.53
+103.36%
|
3.21
-74.01%
|
12.36
|
| Common Stock Equity |
|
2.62
-59.80%
|
6.53
+118.33%
|
2.99
-75.80%
|
12.36
|
| Capital Stock |
|
0.01
+200.00%
|
0.00
-99.10%
|
0.22
|
0.00
|
| Common Stock |
|
0.00
|
0.00
|
0.00
|
0.00
|
| Preferred Stock |
|
0.01
+200.00%
|
0.00
-99.10%
|
0.22
|
0.00
|
| Share Issued |
|
1.69
+1519.15%
|
0.10
+2594.49%
|
0.00
+961.81%
|
0.00
|
| Ordinary Shares Number |
|
1.69
+1519.15%
|
0.10
+2594.49%
|
0.00
+961.81%
|
0.00
|
| Additional Paid In Capital |
|
318.93
+4.44%
|
305.37
+5.06%
|
290.65
+3.90%
|
279.74
|
| Retained Earnings |
|
-316.31
-5.86%
|
-298.79
-3.88%
|
-287.63
-7.56%
|
-267.42
|
| Gains Losses Not Affecting Retained Earnings |
|
0.01
+117.02%
|
-0.05
-51.61%
|
-0.03
-181.58%
|
0.04
|
| Other Equity Adjustments |
|
—
|
—
|
—
|
0.06
|
| Total Equity Gross Minority Interest |
|
2.63
-59.72%
|
6.53
+103.36%
|
3.21
-74.01%
|
12.36
|
| Total Capitalization |
|
2.63
-59.72%
|
6.53
+103.36%
|
3.21
-74.01%
|
12.36
|
| Working Capital |
|
2.15
-65.79%
|
6.30
+25.00%
|
5.04
-72.14%
|
18.08
|
| Invested Capital |
|
2.62
-59.80%
|
6.53
+118.33%
|
2.99
-75.80%
|
12.36
|
| Total Debt |
|
0.33
-39.82%
|
0.55
-28.29%
|
0.76
-22.76%
|
0.98
|
| Capital Lease Obligations |
|
0.33
-39.82%
|
0.55
-28.29%
|
0.76
-22.76%
|
0.98
|
| Net Tangible Assets |
|
2.63
-59.72%
|
6.53
+103.36%
|
3.21
-74.01%
|
12.36
|
| Tangible Book Value |
|
2.62
-59.80%
|
6.53
+118.33%
|
2.99
-75.80%
|
12.36
|
| Derivative Product Liabilities |
|
0.39
-16.88%
|
0.47
-83.54%
|
2.84
-58.61%
|
6.87
|
| Foreign Currency Translation Adjustments |
|
0.01
+117.02%
|
-0.05
-51.61%
|
-0.03
-72.22%
|
-0.02
|
| Inventories Adjustments Allowances |
|
-0.08
+65.96%
|
-0.23
-213.33%
|
-0.07
+48.28%
|
-0.14
|
| Preferred Stock Equity |
|
0.01
+200.00%
|
0.00
-99.10%
|
0.22
|
—
|
| Unrealized Gain Loss |
|
—
|
—
|
—
|
0.06
|
| Line Item | Trend | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|---|
| Operating Cash Flow |
|
-10.81
-12.71%
|
-9.59
+46.53%
|
-17.94
-18.40%
|
-15.15
|
| Cash Flow From Continuing Operating Activities |
|
-10.81
-12.71%
|
-9.59
+46.53%
|
-17.94
-18.40%
|
-15.15
|
| Net Income From Continuing Operations |
|
-17.52
-56.93%
|
-11.16
+44.75%
|
-20.21
-39.13%
|
-14.53
|
| Depreciation Amortization Depletion |
|
0.42
+34.52%
|
0.31
-14.36%
|
0.36
-2.69%
|
0.37
|
| Depreciation |
|
0.42
+34.52%
|
0.31
|
—
|
—
|
| Depreciation And Amortization |
|
0.42
+34.52%
|
0.31
-14.36%
|
0.36
-2.69%
|
0.37
|
| Other Non Cash Items |
|
10.55
+88.21%
|
5.61
+60.98%
|
3.48
-62.33%
|
9.25
|
| Stock Based Compensation |
|
0.13
-73.43%
|
0.48
-28.66%
|
0.67
-22.27%
|
0.86
|
| Operating Gains Losses |
|
-4.13
+8.48%
|
-4.52
-448.72%
|
-0.82
+92.97%
|
-11.70
|
| Gain Loss On Investment Securities |
|
-4.13
+10.44%
|
-4.62
-460.75%
|
-0.82
+92.97%
|
-11.70
|
| Net Foreign Currency Exchange Gain Loss |
|
—
|
—
|
—
|
—
|
| Gain Loss On Sale Of PPE |
|
0.00
-100.00%
|
0.10
|
0.00
|
—
|
| Change In Working Capital |
|
-0.25
+17.05%
|
-0.30
+78.52%
|
-1.42
-337.46%
|
0.60
|
| Change In Receivables |
|
0.23
+4.46%
|
0.22
+141.10%
|
-0.55
+16.92%
|
-0.66
|
| Changes In Account Receivables |
|
0.23
+4.46%
|
0.22
+141.10%
|
-0.55
+16.92%
|
-0.66
|
| Change In Inventory |
|
-0.19
-168.82%
|
0.28
-59.97%
|
0.70
+397.86%
|
0.14
|
| Change In Payables And Accrued Expense |
|
0.41
+164.86%
|
-0.63
+58.27%
|
-1.50
-217.37%
|
1.28
|
| Change In Other Working Capital |
|
-0.17
-686.36%
|
-0.02
-214.29%
|
-0.01
+92.71%
|
-0.10
|
| Change In Other Current Assets |
|
-0.53
-230.00%
|
-0.16
-146.15%
|
-0.07
+4.41%
|
-0.07
|
| Investing Cash Flow |
|
-0.09
-50.00%
|
-0.06
-118.18%
|
0.33
-97.76%
|
14.73
|
| Cash Flow From Continuing Investing Activities |
|
-0.09
-50.00%
|
-0.06
-118.18%
|
0.33
-97.76%
|
14.73
|
| Net PPE Purchase And Sale |
|
-0.09
-50.00%
|
-0.06
+59.73%
|
-0.15
-22.13%
|
-0.12
|
| Purchase Of PPE |
|
-0.09
-50.00%
|
-0.06
+59.73%
|
-0.15
-22.13%
|
-0.12
|
| Sale Of PPE |
|
—
|
—
|
—
|
—
|
| Capital Expenditure |
|
-0.09
-50.00%
|
-0.06
+75.81%
|
-0.25
-103.28%
|
-0.12
|
| Net Investment Purchase And Sale |
|
—
|
0.00
-100.00%
|
0.58
-96.11%
|
14.85
|
| Purchase Of Investment |
|
—
|
—
|
—
|
0.00
|
| Sale Of Investment |
|
—
|
0.00
-100.00%
|
0.58
-96.11%
|
14.85
|
| Net Intangibles Purchase And Sale |
|
—
|
0.00
+100.00%
|
-0.10
|
0.00
|
| Purchase Of Intangibles |
|
—
|
0.00
+100.00%
|
-0.10
|
0.00
|
| Financing Cash Flow |
|
6.94
-36.69%
|
10.96
+197.64%
|
3.68
-60.91%
|
9.42
|
| Cash Flow From Continuing Financing Activities |
|
6.94
-36.69%
|
10.96
+197.64%
|
3.68
-60.91%
|
9.42
|
| Net Issuance Payments Of Debt |
|
—
|
0.00
+100.00%
|
-0.03
-7.69%
|
-0.03
|
| Repayment Of Debt |
|
—
|
0.00
+100.00%
|
-0.03
-7.69%
|
-0.03
|
| Long Term Debt Payments |
|
—
|
0.00
+100.00%
|
-0.03
-7.69%
|
-0.03
|
| Net Long Term Debt Issuance |
|
—
|
0.00
+100.00%
|
-0.03
-7.69%
|
-0.03
|
| Net Common Stock Issuance |
|
6.94
-12.45%
|
7.93
+275.87%
|
2.11
-77.68%
|
9.45
|
| Proceeds From Stock Option Exercised |
|
0.00
-100.00%
|
2.53
+2011.67%
|
0.12
|
0.00
|
| Changes In Cash |
|
-3.96
-402.06%
|
1.31
+109.42%
|
-13.92
-254.68%
|
9.00
|
| Effect Of Exchange Rate Changes |
|
0.06
+443.75%
|
-0.02
-23.08%
|
-0.01
-85.71%
|
-0.01
|
| Beginning Cash Position |
|
5.09
+34.08%
|
3.80
-78.58%
|
17.74
+102.89%
|
8.74
|
| End Cash Position |
|
1.19
-76.64%
|
5.09
+34.08%
|
3.80
-78.58%
|
17.74
|
| Free Cash Flow |
|
-10.90
-12.94%
|
-9.65
+46.93%
|
-18.18
-19.08%
|
-15.27
|
| Income Tax Paid Supplemental Data |
|
0.01
+0.00%
|
0.01
-41.67%
|
0.01
+33.33%
|
0.01
|
| Common Stock Issuance |
|
6.94
-12.45%
|
7.93
+275.87%
|
2.11
-77.68%
|
9.45
|
| Issuance Of Capital Stock |
|
6.94
-17.66%
|
8.43
+134.70%
|
3.59
-62.00%
|
9.45
|
| Net Preferred Stock Issuance |
|
0.00
-100.00%
|
0.50
-66.19%
|
1.48
|
0.00
|
| Preferred Stock Issuance |
|
0.00
-100.00%
|
0.50
-66.19%
|
1.48
|
0.00
|
SEC Filings
Recent 10-K, 10-Q, 8-K, and Form 4 (insider) filings.
- 8-K2026-04-24 View
- 8-K2026-03-27 View
- 8-K2026-03-17 View
- 10-K2026-03-11 View
- 8-K2026-03-10 View
- 8-K2026-02-26 View
- 8-K2026-01-30 View
- 8-K2026-01-23 View
- 10-Q2025-11-12 View
- 8-K2025-11-12 View
- 8-K2025-10-08 View
- 8-K2025-09-30 View
- 8-K2025-09-18 View
- 8-K2025-09-09 View
- 8-K2025-09-03 View
- 8-K2025-08-21 View
- 8-K2025-08-19 View
- 10-Q2025-08-14 View
- 8-K2025-08-14 View
- 8-K2025-08-04 View
Trades
| Date | User | Broker | Pattern | Type | Position Size | Entry Price | Trade P&L | Status |
|---|
Posts
| Published | Title | Author | Category |
|---|